- Joined
- May 21, 2024
- Messages
- 720 (3.40/day)
As Intel's recent challenges continue, the company just sold its 1.18 million share stake in Arm Holdings during Q2, as revealed in a recent regulatory filing, according to Reuters. The sale potentially generated around $146.7 million for Intel, based on Arm's average stock price between April and June. The company recently announced plans to reduce its workforce by over 15% (about 15,000 jobs) and suspend dividend payments, reflecting a downturn in traditional data center semiconductor demand and a shift towards AI chips, a sector where Intel trails competitors like NVIDIA.
CEO Pat Gelsinger is steering Intel towards developing advanced AI chips and expanding its contract manufacturing capabilities, aiming to regain ground lost to Taiwan's TSMC, the industry's leading contract chipmaker. This strategic pivot has increased costs and squeezed profit margins, necessitating cost-cutting measures.
When approached by Reuters, both Intel and Arm declined to comment on the share sale. As of June's end, Intel reported cash and equivalents of $11.29 billion, with total current liabilities around $32 billion. The company's stock has declined by over 59% year-to-date, with a sharp 26% drop on August 2 following the dividend suspension announcement.
Intel kept its investments in some companies like Astera Labs, Joby Aviation, MariaDB, and Senti Biosciences, even though it sold its Arm shares. However, these investments aren't doing well right now. In the second quarter of the year, Intel lost about $120 million on these investments combined.
View at TechPowerUp Main Site | Source
CEO Pat Gelsinger is steering Intel towards developing advanced AI chips and expanding its contract manufacturing capabilities, aiming to regain ground lost to Taiwan's TSMC, the industry's leading contract chipmaker. This strategic pivot has increased costs and squeezed profit margins, necessitating cost-cutting measures.
When approached by Reuters, both Intel and Arm declined to comment on the share sale. As of June's end, Intel reported cash and equivalents of $11.29 billion, with total current liabilities around $32 billion. The company's stock has declined by over 59% year-to-date, with a sharp 26% drop on August 2 following the dividend suspension announcement.
Intel kept its investments in some companies like Astera Labs, Joby Aviation, MariaDB, and Senti Biosciences, even though it sold its Arm shares. However, these investments aren't doing well right now. In the second quarter of the year, Intel lost about $120 million on these investments combined.
View at TechPowerUp Main Site | Source